117 related articles for article (PubMed ID: 38354331)
1. Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities.
Gasoyan H; Anwer F; Casacchia NJ; Kovach JD; Valent J; Wang M; Halpern MT; Rothberg MB
JCO Oncol Pract; 2024 May; 20(5):699-707. PubMed ID: 38354331
[TBL] [Abstract][Full Text] [Related]
2. Treatment Patterns and Clinical and Economic Outcomes in Patients With Newly Diagnosed Multiple Myeloma Treated With Lenalidomide- and/or Bortezomib-containing Regimens Without Stem Cell Transplant in a Real-world Setting.
Chari A; Parikh K; Ni Q; Abouzaid S
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):645-655. PubMed ID: 31377207
[TBL] [Abstract][Full Text] [Related]
3. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.
Ailawadhi S; Frank RD; Advani P; Swaika A; Temkit M; Menghani R; Sharma M; Meghji Z; Paulus S; Khera N; Hashmi SK; Paulus A; Kakar TS; Hodge DO; Colibaseanu DT; Vizzini MR; Roy V; Colon-Otero G; Chanan-Khan AA
Cancer Med; 2017 Dec; 6(12):2876-2885. PubMed ID: 29105343
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States.
Warren JL; Harlan LC; Stevens J; Little RF; Abel GA
J Clin Oncol; 2013 Jun; 31(16):1984-9. PubMed ID: 23569317
[TBL] [Abstract][Full Text] [Related]
5. Malnutrition and Adverse Outcomes After Surgery for Head and Neck Cancer.
Reed WT; Jiang R; Ohnuma T; Kahmke RR; Pyati S; Krishnamoorthy V; Raghunathan K; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):14-21. PubMed ID: 37883116
[TBL] [Abstract][Full Text] [Related]
6. Race and Insurance Status as Predictors of Bicycle Trauma Outcome in Adults.
Chen H; Scarborough J; Zens T; Brummeyer B; Agarwal S; Haines KL
J Surg Res; 2020 Jan; 245():198-204. PubMed ID: 31421362
[TBL] [Abstract][Full Text] [Related]
7. Association of insurance status with health outcomes following traumatic injury: statewide multicenter analysis.
Chikani V; Brophy M; Vossbrink A; Hussaini K; Salvino C; Skubic J; Martinez R
West J Emerg Med; 2015 May; 16(3):408-13. PubMed ID: 25987915
[TBL] [Abstract][Full Text] [Related]
8. Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States.
Medhekar R; Ran T; Fu AZ; Patel S; Kaila S
BMC Cancer; 2022 Aug; 22(1):901. PubMed ID: 35982416
[TBL] [Abstract][Full Text] [Related]
9. Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.
Korde N; Roschewski M; Zingone A; Kwok M; Manasanch EE; Bhutani M; Tageja N; Kazandjian D; Mailankody S; Wu P; Morrison C; Costello R; Zhang Y; Burton D; Mulquin M; Zuchlinski D; Lamping L; Carpenter A; Wall Y; Carter G; Cunningham SC; Gounden V; Sissung TM; Peer C; Maric I; Calvo KR; Braylan R; Yuan C; Stetler-Stevenson M; Arthur DC; Kong KA; Weng L; Faham M; Lindenberg L; Kurdziel K; Choyke P; Steinberg SM; Figg W; Landgren O
JAMA Oncol; 2015 Sep; 1(6):746-54. PubMed ID: 26181891
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Chhabra S; Callander N; Watts NL; Costa LJ; Thapa B; Kaufman JL; Laubach J; Sborov DW; Reeves B; Rodriguez C; Chari A; Silbermann R; Anderson LD; Bal S; Dhakal B; Nathwani N; Shah N; Medvedova E; Bumma N; Holstein SA; Costello C; Jakubowiak A; Wildes TM; Schmidt T; Orlowski RZ; Shain KH; Cowan AJ; Dholaria B; Cornell RF; Jerkins JH; Pei H; Cortoos A; Patel S; Lin TS; Usmani SZ; Richardson PG; Voorhees PM
Transplant Cell Ther; 2023 Mar; 29(3):174.e1-174.e10. PubMed ID: 36494017
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Access to Mental Health Services Among Patients Hospitalized for Deliberate Drug Overdose.
Charron E; Francis EC; Heavner-Sullivan SF; Truong KD
Psychiatr Serv; 2019 Sep; 70(9):758-764. PubMed ID: 31084295
[TBL] [Abstract][Full Text] [Related]
12. Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Jakubowiak A; Usmani SZ; Krishnan A; Lonial S; Comenzo RL; Wang J; de Boer C; Deraedt W; Weiss BM; Schecter JM; Chari A
Clin Lymphoma Myeloma Leuk; 2021 Oct; 21(10):701-710. PubMed ID: 34274290
[TBL] [Abstract][Full Text] [Related]
13. Disparities in mortality after abdominal aortic aneurysm repair are linked to insurance status.
Rozental O; Ma X; Weinberg R; Gadalla F; Essien UR; White RS
J Vasc Surg; 2020 Nov; 72(5):1691-1700.e5. PubMed ID: 32173191
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma, race, insurance and treatment.
Joshi H; Lin S; Fei K; Renteria AS; Jacobs H; Mazumdar M; Jagannath S; Bickell NA
Cancer Epidemiol; 2021 Aug; 73():101974. PubMed ID: 34243048
[TBL] [Abstract][Full Text] [Related]
15. Insurance type and sepsis-associated hospitalizations and sepsis-associated mortality among US adults: a retrospective cohort study.
O'Brien JM; Lu B; Ali NA; Levine DA; Aberegg SK; Lemeshow S
Crit Care; 2011; 15(3):R130. PubMed ID: 21605427
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma.
Mian H; Fiala M; Wildes TM
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):98-104.e1. PubMed ID: 31843543
[TBL] [Abstract][Full Text] [Related]
17. Cumulative incidence of ACL reconstruction after ACL injury in adults: role of age, sex, and race.
Collins JE; Katz JN; Donnell-Fink LA; Martin SD; Losina E
Am J Sports Med; 2013 Mar; 41(3):544-9. PubMed ID: 23302260
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
Mahal AR; Mahal BA; Nguyen PL; Yu JB
Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
[TBL] [Abstract][Full Text] [Related]
19. Vital Signs: Hepatitis C Treatment Among Insured Adults - United States, 2019-2020.
Thompson WW; Symum H; Sandul A; ; Gupta N; Patel P; Nelson N; Mermin J; Wester C
MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(32):1011-1017. PubMed ID: 35951484
[TBL] [Abstract][Full Text] [Related]
20. Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.
Hao S; Snyder RA; Irish W; Parikh AA
PLoS Med; 2021 Oct; 18(10):e1003842. PubMed ID: 34695123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
